Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole

Journal of Clinical Microbiology

Volumn 40, Issue 5, 2002, Pages 1694-1697

  Pfaller, M A ^a   Diekema, D J ^a   Messer, S A ^a   Boyken, L ^a   Huynh, H ^a   Hollis, R J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ARTICLE; CANDIDA; DRUG SCREENING; DRUG SENSITIVITY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL;

ANTIFUNGAL AGENTS; CANDIDA; FREEZING; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; THIAZOLES; TRIAZOLES;

CANDIDA;

EID: 0036251145     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.5.1694-1697.2002     Document Type: Article

References (16)

1. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
2. In vitro antifungal susceptibility testing
3. Antibacterial susceptibility tests: Dilution and disk diffusion methods
4. Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testing
5. Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates
6. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870
7. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing
8. In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, SCH 56592, and voriconazole
9. Antifungal susceptibility testing. New technology and clinical applications
10. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program
11. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans
12. Practice guidelines for the treatment of candidiasis
13. Antifungal susceptibility testing: Practical aspects and current challenges
14. Candida, Cryptococcus, and other yeasts of medical importance